Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure (B-AHEF)
|ClinicalTrials.gov Identifier: NCT01822808|
Recruitment Status : Unknown
Verified August 2015 by Prof. Karen Sliwa, University of Cape Town.
Recruitment status was: Active, not recruiting
First Posted : April 2, 2013
Last Update Posted : August 14, 2015
University of Cape Town
Momentum Research, Inc.
Information provided by (Responsible Party):
Prof. Karen Sliwa, University of Cape Town
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||January 2016|
|Estimated Study Completion Date :||July 2016|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Sliwa K, Damasceno A, Davison BA, Mayosi BM, Sani MU, Ogah O, Mondo C, Ojji D, Dzudie A, Kouam CK, Yonga G, Ba SA, Ogola E, Edwards C, Milo O, Cotter G. Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF). Eur J Heart Fail. 2016 Oct;18(10):1248-1258. doi: 10.1002/ejhf.581. Epub 2016 May 20.